Announcements LOREM IPSUM

Terms of Use

This Website (the “Website”), is provided by SalioGen Therapeutics, Inc. and its affiliates (“SalioGen,” “we,” “our,” or “us”) to the person accessing the Website (“you,” or “your”).

1. You Agree to These Terms by Using the Website

Your access to, and use of, the Website is subject to these Website Terms of Use (“Terms of Use”) and all applicable laws and regulations. By accessing and using the Website, you accept, without limitation or qualification, these Terms of Use. SalioGen may, at any time and without notice, modify these Terms of Use. If we modify these Terms of Use, we will post the revised Terms of Use on the Website. Your continued use of the Website constitutes your acceptance of any such revisions. You should therefore periodically visit this page to review the current Terms of Use. You may not modify these Terms of Use except in a writing signed by SalioGen. Terms of Use constitute the entire agreement between you and us and govern your use of the Website, and supersede any and all prior agreements, written or oral, between you and us regarding the Website (including, without limitation, any prior versions of these Terms of Use).

If you do not agree and accept, without limitation or qualification, these Terms of Use, you must exit the Website immediately.

2. Permitted Use of the Website

The information and materials on the Website are provided for general informational purposes. You may use the Website solely for the purpose of learning about SalioGen services or products. You may not use, modify, reproduce, display, perform, or distribute the text, graphics, downloads, Trademarks, videos, audio, or images or any other content on the Website for any commercial, non-personal purpose without SalioGen’s written permission. You should assume that everything you see or read on this Website is copyrighted unless otherwise noted and may not be used except as provided in these Terms of Use or in the text on the Website without SalioGen’s written permission. We do not represent or warrant that any information on the Website does not infringe or violate the intellectual property rights or other proprietary rights of any third party.

3. No Medical Advice

The information on the Website is not medical advice. If you have a medical condition, please contact your physician or healthcare provider.

4. Notice; Electronic Communications

When you visit the Website or send e-mails to SalioGen, you are communicating with us electronically. You consent to receive communications from us electronically. We will communicate with you by e-mail or by posting notices on the Website. You agree that all agreements, notices, disclosures and other communications that we provide to you electronically satisfy any legal requirement that such communications be in writing.

5. Privacy

SalioGen’s Privacy Policy (above) is incorporated and made part of these Terms of Use. You hereby agree to such Privacy Policy. Any personal data (for example, your name, address, telephone number or e-mail address) that you transmit to the Website by electronic mail or otherwise will be used by SalioGen in accordance with the Privacy Policy. Any other communication or material you transmit to the Website, such as questions, comments, suggestions or the like, will be treated as non-confidential and non-proprietary.

6. Disclaimer; Warranties and Representations

The Website, its content, materials, SERVICES and products on the Website are provided “as is.”  To the fullest extent permissible pursuant to applicable law, SALIOGEN HEREBY disclaims all warranties and indemnities, express or implied, including, but not limited to, implied warranties of merchantability and fitness for a particular purpose and non-infringement.

SalioGen does not represent or warrant that the functions contained in the Website will be uninterrupted or error-free, that the defects will be corrected, or that the Website or the server that makes the Website available are free of viruses or other harmful components. SalioGen does not make any warranties or representations regarding the use of the materials on the Website in terms of their correctness, accuracy, adequacy, usefulness, timeliness, reliability or otherwise. SalioGen does not make any warranties or representations regarding the security of your personal information. Some states do not permit limitations or exclusions on warranties, so the above limitations may not apply to you.

7. Indemnification

You agree to indemnify, defend, and hold harmless SalioGen and its affiliates, and their respective officers, directors, employees, agents, licensors and partners from and against all losses, expenses, damages and costs, including reasonable attorneys’ fees, resulting from or arising out of any violation of these Terms of Use by you or any other person accessing the Website using your Internet account.

8. Limitations of Liability

Your use of the website is at your own risk. Neither saliogen, nor any of its subsidiaries, affiliates, officers or directors, employees nor any of its agents or any other party involved in creating, producing, or delivering the website or its content, are liable for any direct, indirect, punitive, incidental, special, consequential or other damages arising out of or in any way connected with the use of the website whether based on contract, tort, strict liability or otherwise, even if advised of the possibility of any such damages.

9. Third-Party Links

In an attempt to provide increased value to our visitors, SalioGen may link to Websites operated by third parties (“Linked Sites”). SalioGen has no control over Linked Sites, all of which may have separate privacy and data collection practices, independent of SalioGen. Linked Sites are only for your convenience and therefore you access them at your own risk. The availability of any Linked Website is not an endorsement of the content, or any products or services available on such Websites, or an endorsement of any Linked Website’s owners, or its providers. You acknowledge and agree that you access these Linked Sites at your own risk. Any interactions or business dealings with advertisers or third parties other than SalioGen found on or through our Website are solely between you and such advertiser or other third party. Without limiting the foregoing, SalioGen will not be responsible or liable, directly or indirectly, for any actual or alleged damage or loss caused by or in connection with use of or reliance on any such Linked Website and SalioGen expressly disclaims any responsibility for such Websites.

SalioGen does not endorse the content, or any products or services available, on such Websites. Nonetheless, SalioGen seeks to protect the integrity of its Website and the links placed upon it and therefore requests any feedback on not only its own Website, but for Websites it links to as well (including if a specific link does not work).

10. Trademarks

The trademarks, service marks, trade names and logos, whether registered or unregistered (collectively, the “Trademarks”) displayed on the Website are Trademarks of SalioGen and others. You may not use any Trademarks displayed on the Website without our written consent. Nothing contained on the Website should be construed as granting by implication, estoppel, or otherwise, any license or right to use an Trademark displayed on the Website. You may not link to the Website without our prior written consent.

11. Copyright

Copyright © 2021 SalioGen Therapeutics, Inc. ALL RIGHTS RESERVED WORLDWIDE.

All content included on the Website, such as text, graphics, logos, button icons, images, audio clips, digital downloads, data compilations, and software, is the property of SalioGen or its content suppliers, and you should assume is protected by United States and international copyright laws. The compilation of all content on the Website is the exclusive property of SalioGen and protected by United States and international copyright laws. All software used on the Website is the property of SalioGen or its software suppliers, and you should assume is protected by United States and international copyright laws. You agree not to change or delete any proprietary notices from materials printed or downloaded from the Website.

12. Export Control

Software and other materials downloaded or otherwise made available from the Website may be subject to United States Export Control. The United States Export Control laws prohibit the export of certain technical data and software to certain territories. No software from the Website may be downloaded or exported: into (or to a national or resident of) Cuba, Iraq, Libya, North Korea, Iran, Sudan, Syria, or any other country to which the United States has embargoed goods; or anyone on the United States Treasury Department’s list of Specially Designated Nationals or the United States Commerce Department’s Table of Deny Orders.

SalioGen does not authorize the downloading or exportation of any software or technical data from the Website to any jurisdiction prohibited by the United States Export Control Laws.

13. Law and Jurisdiction

These Terms of Use and your use of the Website are governed by the laws of the State of Delaware, without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with the Website or these Terms of Use will be brought solely in the United States District Courts located in Delaware or the state courts located  in the State of Delaware (in each case, in any court having jurisdiction over appeals from such courts), as appropriate, and you consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. Notwithstanding the foregoing, we will at all times have the right to commence proceedings in any other court of our choice with the appropriate jurisdiction for interim injunctive relief.  To the extent allowed by applicable law, any claim or cause of action arising from or relating to your access or use of the Website must be brought within one year from the date on which such claim or action arose or accrued.

14. Assignment

SalioGen may assign its rights and duties under these Terms of Use to any party at any time without notice to you. You may not assign or otherwise transfer the Terms of Use or any right granted hereunder. Any assignment in violation of this section will be null and void.

15. Questions and Feedback

We welcome your questions, comments, and concerns about the Website. Please send us any and all feedback pertaining to the Website to If you choose to submit questions, comments, ideas, feedback or the like, you agree that we are free to use them for any purpose without any restriction or compensation to you. Our use of such information may include but is not limited to developing, manufacturing and marketing products. By accepting your submission, SalioGen does not give up any rights to use similar or related feedback, ideas, concepts, know-how, techniques or other information previously known to us, or developed by our employees, or obtained from sources other than you.

16. General

  1. Any express waiver or failure to exercise promptly any right under the Terms of Use will not create a continuing waiver or any expectation of non-enforcement. If any provision of these Terms of Use is held invalid by any law or regulation of any government, or by any court or arbitrator, the parties agree that such provision will be replaced with a new provision that accomplishes the original business purpose, and the other provisions of the Terms of Use will remain in full force and effect.
  2. SalioGen reserves the right at all times to disclose any information as SalioGen deems necessary to satisfy any applicable law, regulation, legal process or governmental request, or to edit, refuse to post or to remove any information or materials, in whole or in part, in SalioGen’s sole discretion.
  3. You agree that SalioGen may provide notice to you via email, regular mail, or posting notices or links to notices on our Website.
  4. A printed version of these Terms of Use and of any notices given in electronic form will be admissible in judicial or administrative proceedings based upon or relating to these Terms of Use to the same extent and subject to the same conditions as other business documents and records originally generated and maintained in printed form.

This document was last updated on 6/28/2021.

Jason F. Cole

CEO & Chairman of the Board

Jason is a strategic biotechnology CEO and board member with over 20 years of experience working with public and private biotech companies focused on strategy, capital raising, business development, operations, and enabling teams.

Jason joined SalioGen from bluebird bio, where he served as Chief Strategy and Financial Officer, Chief Business Officer, and Chief Operating and Legal Officer, providing strategic, financial, operational, and legal oversight during key growth and transition periods. In these roles, bluebird bio scaled from 100 to 1,200 employees (U.S. & Europe), secured FDA approval of three first-of-their-kind gene and cell therapies (ZYNTEGLO, SKYSONA, ABECMA), and closed over $3.7 billion in financings and strategy-enabling business development transactions. Before bluebird bio, Jason held positions on the executive leadership teams of Zalicus and CombinatoRx, with responsibility across corporate development, strategic alliances, legal, IT, and facilities.

Jason earned a J.D. from Columbia University and an A.B. in Government from Dartmouth College.

Joseph J. Higgins, M.D.

Chief Innovation Officer, Co-Founder & Board Member

Joe is an executive leader, clinician, and scientist dedicated to advancing gene therapies for children and adults with genetic disorders involving the cardiovascular, ophthalmological, neurological, and immunological systems. His background spans pediatrics, child neurology, medical genetics, and molecular developmental neurobiology.

Earlier in his career, Joe worked on the Human Genome Project as the lead of the Human Genetic Initiative. His academic background includes positions as an instructor at Harvard Medical School, an Assistant Professor at George Washington University, an Associate Professor at SUNY Albany, and a Professor at Cornell University. As the Vice President of Clinical Development at uniQure, Joe led Phase 1/2 first-in-human gene therapy trials in Huntington’s disease.

Joe received his medical degree from New York University and graduated cum laude with a B.A. in Biology from Marist College. He is double-board certified in Pediatrics and Neurology with Special Qualification in Child Neurology. He is licensed to practice medicine in New York and Massachusetts.

Jeff Kopacz, M.S., J.D.

Senior Vice President, Intellectual Property & Contracts

Jeff has extensive intellectual property (IP) experience, including building and defending IP protection for platform-based technologies and FDA-approved therapeutics.

Previously, Jeff served as Vice President of Intellectual Property at Omega Therapeutics, leading IP and contract activities related to their genomic control technology. Before Omega, Jeff worked at Alnylam Pharmaceuticals for ten years, most recently as Senior Director, Senior Intellectual Property counsel.

Earlier, Jeff was an attorney at Edwards Angell Palmer & Dodge LLP (now Locke Lord LLP) Jeff began his biopharma career at Millennium Pharmaceuticals (now Takeda Pharmaceuticals).

Jeff received his undergraduate degree in microbiology from the University of Massachusetts at Amherst, his graduate degree in molecular microbiology and immunology from Johns Hopkins University, and a law degree from Suffolk University Law School.

Kate Lewis

Vice President, Portfolio and Program Management

Kate is a biotech leader with 20 years of experience in life sciences and drug development, including extensive work in gene therapy. Her focus is portfolio management, strategic planning, communications, and team leadership.

Prior to SalioGen, Kate served as Vice President, Program Lead and Head of Program Management at Syndax Pharmaceuticals and Freeline Therapeutics. Before that, Kate spent nearly seven years at bluebird bio in roles in Medical Affairs and Program Leadership.

Kate holds a B.A. from Pomona College and an M.A. from the University of Iowa, both in English literature.

Will McGowan

Executive Director, Finance & FP&A

Will is a financial leader with over 15 years of experience working in both public and private biotech companies at all stages of development, from discovery through commercialization.

Will most recently was the Senior Director of FP&A for Allena Pharmaceuticals. Before that role, He spent five years as the Senior Director of Finance and Controller for Navitor Pharmaceuticals and nine years at AMAG Pharmaceuticals in various roles, including Controller and Director of FP&A.

Will holds an MBA from Quinnipiac University and a Bachelor of Science in Finance and Accounting from the Darla Moore School of Business at the University of South Carolina.

Jill Murray

Vice President, Human Resources

Jill is a senior human resources professional with 20+ years of progressive experience in the biotech industry. Her focus is organizational design, employee development, employee relations, leadership coaching, change management, compensation, benefits administration, and legal compliance.

Jill began her career at ImmunoGen, where she covered all facets of Human Resources and Talent Management during her 14-year tenure. After that, Jill joined Sarepta Therapeutics, where she was responsible for establishing and building the HR Business Partnering function, followed by Rubius Therapeutics where she served as Head of Human Resources.

Jill holds a bachelor’s degree in art and psychology from Carnegie Mellon University and is a certified Executive Coach.

Sandeep Nema, Ph.D.

Senior Vice President, Technical Operations

Sandeep has extensive developmental experience in bringing candidates to clinic that span various modalities, including gene therapy, ADCs, mAbs, vaccines, oligonucleotides, bi/tri-specific, and CART.

Before SalioGen, Sandeep worked for 24 years at Pfizer. Recently, his team successfully brought Pfizer’s COVID-19 LNP-mRNA vaccine to the clinic and achieved emergency use authorization. In his last role as Executive Director, Biotherapeutics Pharmaceutical Sciences, Global Biologics, Sandeep was responsible for all pre-proof-of-concept biologics projects, approximately 50 in total, from discovery up to Phase 3 start. Before that, Sandeep established the Protein Pharmaceutical R&D group at Pfizer, which included Formulation, Microbiology, and Stability functions. He is also an adjunct Professor at the University of Tennessee.

Sandeep earned his Ph.D. in Pharmaceuticals from the University of Tennessee Health Science Center and his Bachelor of Pharmacy from Banaras Hindu University. He is also a Certified Regulatory Affairs Professional.

Joe Senn, Ph.D.

Senior Vice President, Head of R&D

Joe is an R&D leader with experience in nearly all therapeutic modalities, including small molecules, biologics, antisense, gene editing, and mRNA therapeutics. He most recently served as the Vice President of Nonclinical Development at Moderna Therapeutics, where he and his team were responsible for progressing over 40 candidates into the clinic. Before Moderna, Joe served as Site Head for Drug Safety at Takeda Pharmaceuticals, overseeing the development of all immunology products across the portfolio.

Joe earned his Ph.D. in Pharmacology and Physiology from the University of Rochester School of Medicine and Dentistry and his B.S. from Niagara University.